Table 1.

Baseline patient demographics in the ITT population and BEP

Population	ITT (N = 80)	BEP (n = 33)
Median age, y	68.5	72
Sex, %
F	33.8	33.3
M	66.2	66.7
ECOG PS, %
0	37.2	30.3
1	44.9	63.6
2	18.0	6.1
Baseline IPI, %
High (≥3)	63.8	57.6
Low (0-2)	36.3	42.4
Cell of origin, %
ABC	45.0	51.5
GCB	42.5	39.4
NOS	8.8	6.1
Unclassified	3.8	3.0
Refractory, % *
No	32.5	57.6
Yes	67.5	42.4
Median follow-up period, mo	29.5†	29.5

ABC, activated B-cell–like; GCB, germinal center B-cell; NOS, not otherwise specified.

^*No response or progression or relapse within 6 months of last antilymphoma therapy.

^†Two patients did not complete their first treatment cycle and were not included.